Seegene, Inc. (KOSDAQ:096530)
South Korea · Delayed Price · Currency is KRW 24,950
-250 (-0.99%)
Oct 10, 2025, 3:30 PM KST
Seegene Market Cap
Seegene has a market cap or net worth of 1.15 trillion as of October 10, 2025. Its market cap has decreased by -1.59% in one year.
Market Cap
1.15T
Enterprise Value
747.91B
Revenue
454.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
24,950.00
Market Cap Chart
Since September 10, 2010, Seegene's market cap has increased from 194.31B to 1.15T, an increase of 492.09%. That is a compound annual growth rate of 12.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 1,162.03B | 10.69% |
| Dec 30, 2024 | 1,049.80B | -1.30% |
| Dec 28, 2023 | 1,063.63B | -22.46% |
| Dec 29, 2022 | 1,371.67B | -56.39% |
| Dec 30, 2021 | 3,145.56B | -37.30% |
| Dec 30, 2020 | 5,016.45B | 529.69% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |